Serum Markers Predicting Early Non-Responsiveness to Infliximab in Rheumatoid Arthritis: Tumor Necrosis Factor (TNF)-Alpha, TNFRII, and Interleukin (IL)-17 As Potential Indicators. Iraqi Journal of Medical Sciences, [S. l.], v. 23, n. 1, 2025. DOI: 10.22578/qchesh02. Disponível em: https://iraqijms.com/index.php/jms/article/view/1177. Acesso em: 5 jul. 2025.